BIOSONICS INC

BIOSONICS INC, operating under SIC 3845 in the Electromedical & Electrotherapeutic Apparatus space, develops and distributes diagnostic ultrasound systems and related medical instrumentation that physicians and hospitals rely on for vascular and peripheral imaging; its suite targets vascular surgeons, radiologists, and cardiologists seeking portable, highly detailed imaging in outpatient and acute-care settings. While the company charts its product roadmap around advancing ultrasonic signal processing and ergonomic transducer design, its small-cap profile and segmented revenue expose it to concentrated customer demand, reimbursement fluctuations, and the need to maintain FDA clearances and compliant quality systems in a heavily regulated arena. The most recent SEC disclosure is the Form 10-K filed in April 1999, highlighting the company’s emphasis on operational execution and capital management amid ongoing technology shifts, and investors can reference CIK 352715 for historical context. For the latest filings, view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025